{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:43:45Z","timestamp":1784180625402,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.clinsp.2022.100155","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T23:35:34Z","timestamp":1674171334000},"page":"100155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Could be FOXO3a, miR-96-5p and miR-182-5p useful for Brazilian women with luminal A and triple negative breast cancers prognosis and target therapy?"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2647-9991","authenticated-orcid":false,"given":"Daniele Carvalho Calvano","family":"Mendes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2335-216X","authenticated-orcid":false,"given":"Carlos Marino Cabral Calvano","family":"Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7472-2650","authenticated-orcid":false,"given":"Nat\u00e1lia","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8404-4312","authenticated-orcid":false,"given":"Marcos Desid\u00e9rio","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0774-9404","authenticated-orcid":false,"suffix":"J\u00fanior","given":"Jos\u00e9 Maria","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7295-678X","authenticated-orcid":false,"given":"Katia Candido","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0111-9030","authenticated-orcid":false,"given":"Edmund Chada","family":"Baracat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clinsp.2022.100155_bib0001","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN esti-mates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clinsp.2022.100155_bib0002","series-title":"MS\/SVS\/DASIS\/CGIAE\/Sistema de Informa\u00e7\u00e3o sobre Mortalidade","year":"2020"},{"key":"10.1016\/j.clinsp.2022.100155_bib0003","series-title":"Estimate\/2020 \u2013 Cancer Incidence in Brazil","year":"2019"},{"key":"10.1016\/j.clinsp.2022.100155_bib0004","doi-asserted-by":"crossref","first-page":"16679","DOI":"10.1038\/s41598-018-35149-1","article-title":"Gene prioritization, communality analysis, networking and metabolic integrated pathway to better understand breast cancer pathogenesis","volume":"8","author":"L\u00f3pez-Cort\u00e9s","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.clinsp.2022.100155_bib0005","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1038\/s41598-020-62279-2","article-title":"OncoOmics approaches to reveal essential genes in breast cancer: a panoramic view from pathogenesis to precision medicine","volume":"10","author":"L\u00f3pez-Cort\u00e9s","year":"2020","journal-title":"Sci Rep"},{"issue":"21","key":"10.1016\/j.clinsp.2022.100155_bib0006","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1158\/1078-0432.CCR-10-1282","article-title":"A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer","volume":"16","author":"Nielsen","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"19","key":"10.1016\/j.clinsp.2022.100155_bib0007","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"S\u00f8rlie","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"10.1016\/j.clinsp.2022.100155_bib0008","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","article-title":"Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma","volume":"10","author":"Nielsen","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.clinsp.2022.100155_bib0009","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.breast.2011.07.008","article-title":"Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry","volume":"21","author":"Park","year":"2012","journal-title":"Breast"},{"issue":"5","key":"10.1016\/j.clinsp.2022.100155_bib0010","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1634\/theoncologist.2017-0535","article-title":"Luminal a breast cancer and molecular assays: a review","volume":"23","author":"Gao","year":"2018","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.clinsp.2022.100155_bib0011","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1200\/JCO.2009.24.9284","article-title":"Breast cancer subtypes and the risk of local and regional relapse","volume":"28","author":"Voduc","year":"2010","journal-title":"J Clin Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.clinsp.2022.100155_bib0012","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1245\/s10434-010-1260-4","article-title":"Triple-negative breast cancers: unique clinical presentations and outcomes","volume":"17","author":"Billar","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clinsp.2022.100155_bib0013","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/978-1-4939-1804-1_23","article-title":"Epigenetics in breast and prostate cancer","volume":"1238","author":"Wu","year":"2015","journal-title":"Methods Mol Biol"},{"issue":"10","key":"10.1016\/j.clinsp.2022.100155_bib0014","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3390\/cells8101214","article-title":"Tollefsbol TO. MicroRNAs and epigenetics strategies to reverse breast cancer","volume":"8","author":"Rahman","year":"2019","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.clinsp.2022.100155_bib0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3390\/cancers10090315","article-title":"Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?","volume":"10","author":"Gonzalez dos Anjos","year":"2018","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.clinsp.2022.100155_bib0016","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3390\/ijms17050656","article-title":"Ewing's sarcoma: an analysis of miRNA expression profiles and target genes in paraffin-embedded primary tumor tissue","volume":"17","author":"Parafioriti","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.clinsp.2022.100155_bib0017","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/138920210793175895","article-title":"MicroRNA: biogenesis, function and role in cancer","volume":"11","author":"MacFarlane","year":"2010","journal-title":"Curr Genomics"},{"issue":"6","key":"10.1016\/j.clinsp.2022.100155_bib0018","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/ncb2769","article-title":"Control of metastatic progression by microRNA regulatory networks","volume":"15","author":"Pencheva","year":"2013","journal-title":"Nat Cell Biol"},{"issue":"1","key":"10.1016\/j.clinsp.2022.100155_bib0019","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12943-018-0856-3","article-title":"Critical role of FOXO3a in carcinogenesis","volume":"17","author":"Liu","year":"2018","journal-title":"Mol Cancer"},{"key":"10.1016\/j.clinsp.2022.100155_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-8900-3_1","article-title":"Introduction to FOXO Biology","volume":"1890","author":"Link","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.clinsp.2022.100155_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-015-0156-6","article-title":"Evaluating the evidence for targeting FOXO3a in breast cancer: a systematic review","volume":"15","author":"Taylor","year":"2015","journal-title":"Cancer Cell Int"},{"issue":"2","key":"10.1016\/j.clinsp.2022.100155_bib0022","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/03936155221095879","article-title":"Prognostic value of high FOXO3a expression in patients with solid tumors: A meta-analysis and systematic review","volume":"37","author":"Wang","year":"2022","journal-title":"Int J Biol Markers"},{"issue":"8","key":"10.1016\/j.clinsp.2022.100155_bib0023","doi-asserted-by":"crossref","first-page":"7733","DOI":"10.1007\/s13277-014-2025-7","article-title":"Triple-negative and luminal A breast tumors: differential expression of miR-18a-5p, miR-17-5p, and miR-20a-5p","volume":"35","author":"Calvano Filho","year":"2014","journal-title":"Tumor Biol"},{"key":"10.1016\/j.clinsp.2022.100155_bib0024","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.humpath.2015.08.026","article-title":"May Sonic Hedgehog proteins be markers for malignancy in uterine smooth muscle tumors?","volume":"50","author":"Garcia","year":"2016","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.clinsp.2022.100155_bib0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.molmed.2008.03.002","article-title":"Out FOXOing disease and disability: the therapeutic potential of targeting FoxO proteins","volume":"14","author":"Maiese","year":"2008","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.clinsp.2022.100155_bib0026","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2018.01.004","article-title":"FoxO transcription factors in cancer metabolism","volume":"50","author":"Yadav","year":"2018","journal-title":"Semin Cancer Biol"},{"issue":"9","key":"10.1016\/j.clinsp.2022.100155_bib0027","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3390\/cells8091110","article-title":"FOXO3a from the Nucleus to the Mitochondria: A Round Trip in Cellular Stress Response","volume":"8","author":"Fasano","year":"2019","journal-title":"Cells"},{"issue":"6775","key":"10.1016\/j.clinsp.2022.100155_bib0028","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/35005107","article-title":"An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells","volume":"404","author":"Hammond","year":"2000","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.clinsp.2022.100155_bib0029","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"35","key":"10.1016\/j.clinsp.2022.100155_bib0030","doi-asserted-by":"crossref","first-page":"23204","DOI":"10.1074\/jbc.M109.031427","article-title":"Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells","volume":"284","author":"Guttilla","year":"2009","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.clinsp.2022.100155_bib0031","doi-asserted-by":"crossref","first-page":"e15797","DOI":"10.1371\/journal.pone.0015797","article-title":"Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a","volume":"5","author":"Lin","year":"2010","journal-title":"Plos One"},{"issue":"1","key":"10.1016\/j.clinsp.2022.100155_bib0032","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13048-019-0533-1","article-title":"miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae 1","volume":"12","author":"Liu","year":"2019","journal-title":"J Ovarian Res"},{"issue":"2","key":"10.1016\/j.clinsp.2022.100155_bib0033","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3892\/mmr.2014.2854","article-title":"MicroRNA-96 promotes the proliferation of colorectal cancer cells and targets tumor protein p53 inducible nuclear protein 1, forkhead box protein O1 (FOXO1) and FOXO3a","volume":"11","author":"Gao","year":"2015","journal-title":"Mol Med Rep"},{"issue":"2","key":"10.1016\/j.clinsp.2022.100155_bib0034","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1261\/rna.034926.112","article-title":"MicroRNA-182-5p targets a network of genes involved in DNA repair","volume":"19","author":"Krishnan","year":"2013","journal-title":"RNA"},{"issue":"4","key":"10.1016\/j.clinsp.2022.100155_bib0035","first-page":"1900","article-title":"miR-182 promotes cell proliferation and invasion by inhibiting APC in melanoma","volume":"11","author":"Liu","year":"2018","journal-title":"Int. J Clin Exp Pathol."},{"issue":"1","key":"10.1016\/j.clinsp.2022.100155_bib0036","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1158\/0008-5472.CAN-09-1891","article-title":"Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer","volume":"70","author":"Myatt","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.clinsp.2022.100155_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111279","article-title":"The emerging role of non-coding RNAs in the regulation of PI3K\/AKT pathway in the carcinogenesis process","volume":"137","author":"Ghafouri-Fard","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10.1016\/j.clinsp.2022.100155_bib0038","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00401-012-0969-5","article-title":"Pleiotropic effects of miR-183\u223c96\u223c182 converge to regulate cell survival, proliferation and migration in medulloblastoma","volume":"123","author":"Weeraratne","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.clinsp.2022.100155_bib0039","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0092-8674(04)00302-2","article-title":"I\u03baB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a","volume":"117","author":"Hu","year":"2004","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.clinsp.2022.100155_bib0040","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1186\/bcr1872","article-title":"Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis","volume":"10","author":"Zou","year":"2008","journal-title":"Breast Cancer Res"},{"issue":"10","key":"10.1016\/j.clinsp.2022.100155_bib0041","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.31557\/APJCP.2022.23.10.3361","article-title":"The Role of miRNA-182 and FOXO3 Expression in Breast Cancer","volume":"23","author":"Kandil","year":"2022","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222033567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222033567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T01:32:10Z","timestamp":1725067930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222033567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":41,"alternative-id":["S1807593222033567"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2022.100155","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Could be FOXO3a, miR-96-5p and miR-182-5p useful for Brazilian women with luminal A and triple negative breast cancers prognosis and target therapy?","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2022.100155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100155"}}